Association between plasma lipids, and apolipoproteins and coronary artery disease: a cross-sectional study in a low-risk Korean population

This publication has 21 references indexed in Scilit:

• From Vulnerable Plaque to Vulnerable Patient
  Circulation, 2003
• Apolipoprotein Concentrations During Treatment and Recurrent Coronary Artery Disease Events
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2000
• Secondary Prevention by Raising HDL Cholesterol and Reducing Triglycerides in Patients With Coronary Artery Disease
  Circulation, 2000
• Fasting Insulin and Apolipoprotein B Levels and Low-Density Lipoprotein Particle Size as Risk Factors for Ischemic Heart Disease
  JAMA, 1998
• Apolipoprotein A-I and B Levels and the Risk of Ischemic Heart Disease During a Five-Year Follow-up of Men in the Que´bec Cardiovascular Study
  Circulation, 1996
• Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
  New England Journal of Medicine, 1995
• Plasma levels of apolipoproteins A-1 and B in Indian patients with angiographically defined coronary artery disease
  International Journal of Cardiology, 1994
• Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience)
  The American Journal of Cardiology, 1992
• Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery disease
  Journal of the American College of Cardiology, 1992
• High density lipoprotein as a protective factor against coronary heart disease
  The American Journal of Medicine, 1977